Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Philip Greenberg
Fred Hutchinson Cancer Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Juno Therapeutics
Payment for services (e.g., consulting fees, honoraria, paid authorship)
NA
Adult Leukemia Research Center
Project Narrative Overall The goal of this Program Project Grant is to develop improved, curative therapies for patients with hematological malignancies focusing primarily on adoptive cell therapy and hematopoietic cell transplantation. Individual Projects will explore the clinical use of genetically engineered T cells to treat acute myeloid leukemia and multiple myeloma, and will define the type of graft-versus-host disease prophylaxis that provides the greatest likelihood for survival without either relapse or graft-versus host disease.
Filed on May 14, 2018.
Tell us what you know about Philip Greenberg's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Philip Greenberg”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | Value cannot be readily determined |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | >$600,000 |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | >$600,000 |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | Value cannot be readily determined |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | Value cannot be readily determined |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | Value cannot be readily determined |
| Philip Greenberg | Fred Hutchinson Cancer Research Center | Conflict of Interest | Juno Therapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.